Latest News

  • First Liquid Biopsy Test for Non-Small Cell Lung Cancer, Microsoft Attempts to Transform Cancer Diagnoses and Patient Care, More

    Diagnostics World News | A digital AI platform to enrich breast cancer grading and improve risk categorization; novel tests significantly reduce hospitalization costs and mortality and morbidity rates in newborns and premature infants; the first blood test superior to stool tests in detecting advanced adenomas and colorectal cancer; and more.

    Jan 26, 2023
  • Follow the Money: Gates Foundation Funds Diagnostic Tools for the Underserved, First Fully Remote Subspecialty Diagnostic Service, More

    Diagnostics World News | Funding for a decision-support platform to enhance surveillance, detection, and triage of neglected tropical diseases and other rare infectious diseases, transcriptome-wide profiling and advanced medicinal chemistry technology, novel pathology consulting, and more.

    Jan 24, 2023
  • MRD If You Please: Diagnostics Targets Minimal Residual Disease

    Diagnostics World News | At the J.P. Morgan Healthcare Conference last week, several diagnostics companies offered insight into their directions and plans for the coming year, and oncology diagnostics was a refrain. Across the space, test developers and researcher groups are turning their attention first to minimal residual disease (MRD) tests. Here we gather feedback from a few of the companies that presented last week.

    Jan 19, 2023
  • MRD If You Please: Diagnostics Targets Minimal Residual Disease

    Diagnostics World News | At the J.P. Morgan Healthcare Conference last week, several diagnostics companies offered insight into their directions and plans for the coming year, and oncology diagnostics was a refrain. Across the space, test developers and researcher groups are turning their attention first to minimal residual disease (MRD) tests. Here we gather feedback from a few of the companies that presented last week.

    Jan 19, 2023
  • Cell-Free DNA Assay Could Make Routine Cancer Testing Feasible

    Diagnostics World News | Scientists from the National University of Singapore (NUS) have discovered a blood test for monitoring cancer patients that could be done for as little as $35. The new Heatrich-BS assay sequences cell-free DNA in clinical samples that get heated to isolate cancer-specific signatures, according to Cheow Lih Feng, assistant professor at NUS’s Institute for Health Innovation & Technology and department of biomedical engineering.

    Jan 18, 2023
  • Emerging Tech Aims to Remove Racial Bias from Blood Measurements

    Diagnostics World News | A team of researchers is pursuing new technology to address racial disparities in blood measurements. The group ultimately hopes to develop a portable wearable device, like a monitor or watch, capable of accurately and non-invasively reading blood regardless of skin tone.

    Jan 17, 2023
  • Emerging Tech Aims to Remove Racial Bias from Blood Measurements

    Diagnostics World News | A team of researchers is pursuing new technology to address racial disparities in blood measurements. The group ultimately hopes to develop a portable wearable device, like a monitor or watch, capable of accurately and non-invasively reading blood regardless of skin tone.

    Jan 17, 2023